Back to Journals » International Journal of Women's Health » Volume 10

Risk factors for maternal mortality associated with eclampsia presenting at a Nigerian tertiary hospital

Authors Rabiu KA, Adewunmi AA, Ottun TA, Akinlusi FM, Adebanjo AA, Alausa TG

Received 29 June 2018

Accepted for publication 20 August 2018

Published 6 November 2018 Volume 2018:10 Pages 715—721


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Professor Elie Al-Chaer

Kabiru Afolarin Rabiu,1 Adeniyi Abiodun Adewunmi,1 Tawakwalit Abimbola Ottun,1 Fatimat Motunrayo Akinlusi,1 Adewunmi Adeoye Adebanjo,2 Taiwo Ganiyat Alausa2

1Department of Obstetrics and Gynaecology, Lagos State University College of Medicine, Ikeja, Lagos State, Nigeria; 2Department of Obstetrics and Gynaecology, Lagos State University Teaching Hospital, Ikeja, Lagos State, Nigeria

Background: Eclampsia remains a leading contributor to maternal mortality, particularly in developing countries, and remains a challenge even to the most experienced obstetrician. We aimed to determine the factors associated with maternal mortality in eclamptics at the Lagos State University Teaching Hospital (LASUTH), Nigeria, in order to suggest ways to prevent this avoidable tragedy.
Materials and methods: Data were prospectively collected with the aid of a specially designed proforma from January 1, 2011 to December 31, 2012. Comparison was made between the patients who died (cases) and the survivors (control). Univariate and multivariate analyses were carried out using logistic regression.
Results: The case fatality rate was 19.4%. Factors independently associated with mortality were as follows: period between onset of seizures to arrival in LASUTH >12 hours (adjusted OR=22.04; 95% CI=4.62–104.95; P=0.001), vaginal delivery (adjusted OR=10.96; 95% CI=2.54–47.27; P=0.0013), presence of aspiration pneumonitis (adjusted OR=7.77; 95% CI=2.37–25.46; P=0.0007), and presence of renal failure (adjusted OR=7.09; 95% CI=2.14–23.48; P=0.0014). The use of magnesium sulfate reduced the risk of mortality (adjusted OR=0.25; 95% CI=0.09–0.72; P=0.0104).
Conclusion: Maternal mortality in patients with eclampsia was associated largely with preventable factors. The use of standard obstetric services, prompt referral of patients for definitive care, and the use of simplified dosing regimen of magnesium sulfate may improve its utilization and also improve maternal outcome.

Keywords: maternal mortality, eclampsia, Nigeria

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]